# Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies

> **NCT05611515** · — · RECRUITING · sponsor: **Centre Hospitalier Universitaire UCLouvain Namur** · enrollment: 108 (estimated)

## Conditions studied

- Supraglottic Squamous Cell Carcinoma
- Early Stage (T1-T2, N0-N1,M0)

## Interventions

- **PROCEDURE:** TORS

## Key facts

- **NCT ID:** NCT05611515
- **Lead sponsor:** Centre Hospitalier Universitaire UCLouvain Namur
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-17
- **Primary completion:** 2025-12
- **Final completion:** 2026-12
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2022-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05611515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05611515, "Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05611515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*